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Berberis  hartwegii  Benth.,  Berberidaceae,  Hamelia  patens  Jacq.,  Rubiaceae,  Dendropanax  arboreus  (L.) Decne
& Planch.,  Araliaceae,  Erythrina  herbacea  L., Fabaceae,  and  Zanthoxylum  caribaeum  Lam.,  Rutaceae,  acetone
extracts  were  selected  on the  basis  of  their  use  in  traditional  Mexican  medicine  to treat  scabies  or skin
diseases.  Anti-dermatophyte  activity  in  vitro  was  evaluated  using  the  agar  dilution  assay,  and  the  thera-
peutic  efﬁcacy  of  B. hartwegii  and  Z. caribaeum  were  tested  against  experimental  tinea  pedis.  The infected
animals  were  treated  intragastrically  daily  for seven  days  with  2.5  and  5 mg/kg  of  acetone  extracts.  The
acetone  extract  of H.  patens  exhibited  100%  growth  inhibition  against  T.  mentagrophytes  and  E.  ﬂoccosum
at  100.0  and  50.0  g/ml,  respectively,  and  B. hartwegii  inhibited  growth  of  M.  canis and T. mentagrophytes
at  100.0  g/ml.  Effective  treatments  with  2.5 mg/kg  of  Z. caribaeum  and  B.  hartwegii  extract  were  com-
parable  with  1 mg/kg  of  clotrimazole  in  mice.  Liver  proﬁle  tests  and  histological  analyses  did  not  exhibit
any  signs  of  toxicity  and  the  Ames  test  indicated  that  both  extracts  were  safe  when evaluated  in  strains
TA98,  TA100  and  TA102.  Our results  suggest  the  potential  for  the  future  development  of new  antifungal
drugs  from  B.  hartwegii  or Z.  caribaeum.
©  2014  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Skin, hair and nail fungal infections are common and
idespread. These infections are caused by three groups of fungi:
ermatophytes, yeasts and molds (Schwartz, 2004). Dermato-
hytes are the primary cause of these infections, particularly
richophyton rubrum (Moreno and Arenas, 2010). Dermatophytes
an invade several keratinized tissues and use the keratin as a
arbon, nitrogen and sulfur source. In humans and other animals,
hese fungi can produce an infection known as dermatophytosis
Vermout et al., 2008; Weitzman and Summerbell, 1995).
Superﬁcial mycoses are not life-threatening but are a serious
roblem for the quality of life because these infections can cause
erious discomfort and cosmetic deformities (Koga et al., 2012).
hese diseases are observed worldwide and affect 20–25% of the
orld’s population (Havlickova et al., 2008). The incidences of these
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E-mail: cordaz@ipn.mx (C. Ordaz-Pichardo).
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102-695X/© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorainfections have not changed within the last three decades (Borman
et al., 2007; Havlickova et al., 2008), although many antifungal
drugs with potent action against this species have been introduced
into the market (Brennan and Leyden, 1997; Kumar and Kimball,
2009). Current treatment is based on the use of topical antifungal
agents, or systemic treatments in the case of extended or recurrent
infections (Bell-Syer et al., 2012; Dik et al., 2003). The drugs that
are most commonly used against these diseases include ampho-
tericin B, ketoconazole, ﬂuconazole, terbinaﬁne and clotrimazole
(Khan and Ahmad, 2011). These drugs are sometimes inefﬁcient
and often present nephrotoxicity and hepatotoxicity (Andriole,
1999; Somchit et al., 2004; Zapata-Garrido et al., 2003). In addi-
tion, the dermatophyte resistance to antifungal drugs has resulted
in the need for novel antimycotic agents with a broad spectrum and
fewer side effects (Duraipandiyan et al., 2012; Girois et al., 2006;
Khan and Ahmad, 2011). Thus, a more potent therapeutic drug that
is capable of shortening treatment duration and improving patient
adherence rate would be beneﬁcial (Koga et al., 2012).
Medicinal plants are a source of bioactive compounds used to
treat many diseases. Many plants possess antimicrobial agents and
 Ltda. All rights reserved.
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xhibit antifungal activity (Lemos et al., 2005). Several in vitro
nd in vivo studies using plant products traditionally used in
thnomedicine have demonstrated promising antifungal activity
ithout any side effects (Bajpai et al., 2009; Park et al., 2007;
okovic and Griensven, 2006).
The aim of this study was to evaluate Mexican plants for activity
gainst dermatophyte strains, particularly T. rubrum. Plants were
elected on the basis of their use in traditional medicine to treat
cabies or diseases with related symptoms, such as skin diseases.
cetone extracts from ﬁve plant species were evaluated for antifun-
al activity using the agar dilution assay and “experimental tinea
edis” model in BALB/c mice. In addition, experimental toxicology
tudies, including liver proﬁle tests and the Ames test, were per-
ormed to determine the risk to beneﬁt ratio and the mutagenic
ctivity of the extracts.
aterials and methods
lant material
We  select ﬁve medicinal plants used in traditional Mexi-
an medicine. Berberis hartwegii Benth., Berberidaceae, Hamelia
atens Jacq., Rubiaceae, Dendropanax arboreus (L) Decne & Planch.,
raliaceae, Erythrina herbacea L., Leguminosae, and Zanthoxylum
aribaeum Lam., Rutaceae, were collected by Cynthia Ordaz-
ichardo Ph.D. in 2010 in Gómez Farías, Tamaulipas state, Mexico.
lant identiﬁcations were performed by M.C. Patricia Jácquez-Ríos
t the “IZTA Herbarium” at the Iztacala campus of the National
utonomous University of Mexico (UNAM). A specimen of each
lant was deposited in the herbarium with voucher numbers: B.
artwegii (1759), D. arboreus (1652), E. herbacea (1650), H. patens
1649) and Z. caribaeum (1651). Plants were air-dried and pow-
ered.
xtract preparations
Acetone extracts from the leaves of B. hartwegii and H. patens,
arks of D. arboreus and Z. caribaeum,  and roots from E. herbacea
ere produced by direct maceration of dry and powdered plant
aterial (25 g) for ﬁve days at room temperature in 250 ml  of ace-
one ﬁve times. The extracts were ﬁltered and evaporated under
ow pressure to dryness at 40 ◦C. The collected extracts were stored
t −20 ◦C until further use.
ermatophytes species
Dermatophytes (Epidermophyton ﬂoccosum,  Microsporum canis,
richophyton mentagrophytes, Trichophyton rubrum and Trichophy-
on tonsurans)  are well-characterized clinical isolates from the
train collection of the Hospital Juárez de Mexico and were donated
y Q.F.B. Misael González Ibarra, the chief of the Laboratory of
mmunology and Medical Mycology.
noculum preparation for biological assay
All of the strains were cultured in Sabouraud dextrose broth
Bioxon) at 28 ◦C until the maximal numbers of conidia were
ormed (15–20 days). The conidia were recovered by centrifuga-
ion at 2795 × g for 20 min  at 4 ◦C. The pellet was  suspended in
terilized distilled water and was adjusted to 105 conidia (in vitro)
r 106 conidia (in vivo) per ml  for use as the inoculum. The conidia
ere quantiﬁed using a Neubauer quantiﬁcation chamber under a
icroscope.de Farmacognosia 25 (2015) 22–28 23
Agar dilution assay
The assay was carried out according to the method of Hufford
with some modiﬁcations (Hufford et al., 1975). Agar plates were
prepared by adding 10 ml  of Sabouraud dextrose agar in Petri dishes
(9 cm in diameter). Next, 100, 50 or 25 g of extract were added
in 100 L of dimethyl sulfoxide (DMSO) and control agar plates
with 1% of DMSO and 100 g of clotrimazole were included. The
plates were incubated for 10 min  at room temperature and were
subsequently inoculated with each of the test fungi in triplicate.
The plates were incubated at 28 ◦C for 12 days. These results were
expressed as the percentage of inhibition of hyphal elongation com-
pared to the negative controls.
Determination of therapeutic efﬁcacy against experimental tinea
pedis in BALB/c mice
Male BALB/c eight-week-old mice weighing 25 ± 5 g were used
and ten mice were assigned to each group. The mice were placed
in stainless steel cages, which were maintained at 25 ◦C in a 12 h
dark–light cycle and provided with food and water ad libitum.  All of
the experiments were performed according to the Mexican Ofﬁcial
Norm for Animal Care Handing (NOM-062, 1999).
Procedures for infection
The assay was carried out according to the method of González-
Ávila (González-Ávila, 2002). One side of a paper disk (6 mm in
diameter, Antibiotic Assay Paper, Whatman #1) was covered with
a piece of aluminum foil, and the other side was free to carry the
inoculum suspension. The discs were inoculated with 106 conidia
of T. rubrum and were ﬁxed to the soles of the feet of animal with
adhesive elastic tape. The discs were removed on days 7, 14 and 21,
and each sole was examined for clinical signs of dermatophytosis.
The right leg of each animal was  infected, and the left leg served as
the uninfected control.
Macroscopic observation
The skin lesions caused by T. rubrum were observed macroscop-
ically on days 7, 14 and 21 and were assessed using the following
score system: 0, no signs or normal; 1, a small number of pink
erythematous papules and less than 25% of desquamation at the
site; 2, moderate intense pink erythema spread over the entire site
accompanied by 25–50% desquamation an inﬂammatory response;
3, patches of intense red erythema with 50–80% desquamation
and crusting; and 4, severe carmine red erythema with 80–100%
desquamation and severe crusting. The average score for each
group was  calculated to determine the average lesion score.
Treatment
From day 14 post-infection, the mice were treated intragastri-
cally (IG) daily for seven days with 100 L DMSO:H2O 1:3 serving as
a vehicle. All groups were kept under constant observation to detect
any changes in behavior or changes in water and food intake.
The animals were divided into ﬁve groups: group A was the
non-treated infected control, group B was the positive control
(treated with 1 mg/kg of clotrimazole IG), groups C and D were the
infected groups treated with 2.5 and 5 mg/kg of acetone extract of
B. hartwegii or Z. caribaeum,  respectively, and group E consisted of
non-infected animals treated with 10 mg/kg of extract to determine
the potential toxic effects of extracts.
After treatment, the mice were anesthetized with 60 mg/kg
of intraperitoneal sodium pentobarbital and sacriﬁced by cardiac
puncture to collect 2–3 ml  of blood. Serum from non-heparinized
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Table  1
In vitro activity against E. ﬂoccosum,  M.  canis, T. mentagrophytes, T. rubrum and T. tonsurans (percentage of growth inhibition).
g/ml Epidermophyton ﬂoccosum Microsporum canis Trichophyton mentagrophytes Trichophyton rubrum Trichophyton tonsurans
Berberis hartwegii 25 20.0 ± 0.3 85.0 ± 0.0 6.7 ± 0.4 26.7 ± 0.0 26.7 ± 2.1
50  36.7 ± 6.7 88.3 ± 5.9 26.7 ± 2.1 46.7 ± 0.0 78.3 ± 2.2
100  78.3 ± 6.8 100.0 ± 0.0 100.0 ± 0.0 65.0 ± 0.0 85.0 ± 5.8
Dendropanax arboreus 25 23.3 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 18.3 ± 0.6 40.0 ± .0.0
50  36.7 ± 0.0 20.0 ± 0.0 23.3 ± 1.8 56.7 ± 3.8 60.0 ± 0.0
100  50.0 ± 0.0 28.3 ± 1.1 77.0 ± 0.0 75.0 ± 0.0 90.0 ± 0.0
Erythrina herbacea 25 20.0 ± 0.0 0.0 ± 0.0 3.3 ± 0.2 16.7 ± 1.1 40.0 ± 0.0
50  20.0 ± 0.0 75.0 ± 0.0 13.3 ± 0.9 36.7 ± 3.3 70.0 ± 0.0
100  46.6 ± 5.1 85.0 ± 0.0 33.3 ± 2.9 78.3 ± 5.8 95.0 ± 0.0
Hamelia patens 25 50.0 ± 0.0 70.0 ± 0.0 80.0 ± 0.4 10.0 ± 0.0 73.0 ± 8.7
50  100.0 ± 0.0 83.3 ± 5.4 90.0 ± 0.3 26.7 ± 1.1 90.0 ± 0.3
100  100.0 ± 0.0 97.0 ± 2.9 100.0 ± 0.0 46.7 ± 5.0 92.7 ± 5.9
Zanthoxylum caribaeum 25 13.3 ± 0.9 1.7 ± 0.1 10.0 ± 0.0 6.7 ± 0.4 80.0 ± 0.0
50  56.7 ± 5.8 26.7 ± 4.2 40.0 ± 0.0 20.0 ± 0.0 90.0 ± 0.0
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Clotrimazole 100 100.0 ± 0.0 100.0 ± 0.0 
DMSO  100 L 0.0 ± 0.0 0.0 ± 0.0 
lood was carefully collected for a liver proﬁle test. The mice
ere euthanized according to the ofﬁcial Mexican standard for
he humane killing of animals (NOM-033, 1995). All animals were
uthanized, and the vital organs were macroscopically analyzed.
istological analyses
Representative fragments of the kidney, lungs and liver (to
bserve the toxic effects of extracts) from three mice were ﬁxed
n a 10% solution of formalin and enclosed in parafﬁn. Parafﬁn
locks were prepared after completing tissue processing in differ-
nt grades of alcohol and xylenes. Sections (5 m)  were prepared
rom parafﬁn blocks using a microtome, and the sections were
tained with hematoxylin–eosin (H&E).
utagenicity assay
A Salmonella mutagenicity test using the incorporation method
as performed as previously described (Maron and Ames, 1983),
sing the Salmonella typhimurium strains TA98, TA100 and TA102
nd the S9 fraction obtained from the liver of a male Wistar rat
nduced with Aroclor 1254 (New England Nuclear, North Haven,
onn) as the metabolic activation system. S. typhimurium strains
ere cultured for 16 h at 37 ◦C in a shaking water bath set at
0 rpm. In a sterile tube containing 2 ml  of soft agar (at 45 ◦C),
he bacterial cultures (100 L) were exposed to ﬁnal extract con-
entrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25.0, 50.0, 100 and
00.0 g/ml, or to 10 l of DMSO as a negative control. Sub-
equently, the suspension mixture was placed in a Petri dish
ontaining Vogel–Bonner minimal medium. After incubation for
8 h at 37 ◦C, the revertant colonies (His+) were quantiﬁed. The
utagenesis positive controls used for each strain were picrolonic
cid, methyl-N-nitro-N-nitrosoguanidine, mitomycin C, 2-amino-
nthracene and cyclophosphamide, as previously described (Maron
nd Ames, 1983).
tatistical analysis
GraphPad Prism 5.0 (GraphPad Software, Inc.) was used for
tatistical analysis. The average lesion score on the last day of
acroscopic observation was analyzed using one-way ANOVA non-
arametric test and Dunnett post hoc analysis. The differences of the
eans of the groups were compared with the non-treated group
nd were considered signiﬁcant when p < 0.05.
The mutagenicity was evaluated using a two-way ANOVA test
nd Bonferroni post hoc analysis. The differences of the means of the60.0 ± 0.0 75.0 ± 0.0 93.0 ± 0.0
100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0
0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
groups were compared with the corresponding positive control and
were considered to be signiﬁcant when p < 0.05.
Results
The acetone extracts from B. hartwegii, D. arboreus, E. herbacea,
H. patens and Z. caribaeum (yields of 4.1, 2.5, 2.7, 3.7 and 2.1%
respectively) were evaluated for activity against E. ﬂoccosum,  M.
canis, T. mentagrophytes, T. rubrum and T. tonsurans (Table 1). The
acetone extract of H. patens exhibited 100% growth inhibition
against T. mentagrophytes and E. ﬂoccosum at 100.0 and 50.0 g/ml,
respectively, and B. hartwegii inhibited growth of M.  canis and T.
mentagrophytes at 100.0 g/ml. None of the extracts inhibited 100%
growth of T. tonsurans,  but all of the extracts exhibited good activ-
ity, with 85–95% growth inhibition at 100.0 g/ml. The 1% DMSO
did not affect the growth of the fungi.
The macroscopic observation results in the tinea pedis model are
shown in Fig. 1. At day 7 post-infection, all of the groups exhibited
a small number of pink erythematous papules and less than 25%
of desquamation. At day 14 post-infection, the disease progressed
uniformly in all groups, with patches of intense red erythema and
50–80% of scales and crusting. At day 21 post-infection (7 days
of treatment), the mice treated with B. hartwegii (2.5 mg/kg) or
Z. caribaeum (2.5 and 5 mg/kg) showed improvement in the soles
(Fig. 2), with a level of damage similar to day 7 post-infection, while
the mice treated with B. hartwegii (5 mg/kg) showed an improve-
ment of 100% with no signs of disease. Compared to the non-treated
group, there was  a statistically signiﬁcant improvement in the
lesions treated with B. hartwegii and Z. caribaeum acetone extracts.
The non-infected animals treated with 10 mg/kg of B. hartwegii
or Z. caribaeum did not exhibit signs of toxicity, such as piloerection,
alteration in locomotor activity or mortality. The internal organs did
not exhibit any gross morphological lesions.
The results of the liver proﬁle test showed that the values
of serum glutamic pyruvic transaminase (56.1 ± 9.9 UI/l), serum
glutamic oxaloacetic transaminase (160.2 ± 64.1 UI/l), total biliru-
bin (0.74 ± 0.25 mg/dl), direct bilirubin (0.67 ± 0.28 mg/dl), and
indirect bilirubin (0.90 ± 0.56) did not present any signiﬁcant dif-
ference between the treated groups and control group, indicating
an absence of liver damage caused by treatment.
Kidney sections from animals treated with acetone extracts of
B. hartwegii or Z. caribaeum (10 mg/kg for seven days) showed a
normal renal cortex with a normal appearance of the glomerulus,
tubules and renal papilla. The lung sections displayed normal alve-
olar geometry, and the alveolar septum appeared normal. The liver
sections showed normal hepatic architecture, normal hepatocytes,
a normal portal triad and a normal central vein.
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tig. 1. The macroscopic improvement of skin lesions in experimental tinea pedis in 
ntragastric treatment was  started on day 14 post-inoculation (↓) and was  continue
NOVA nonparametric test and Dunnett post hoc analysis).
Mutagenicity studies by the incorporation method showed
hat the acetone extracts of B. hartwegii, D. arboreus, E. herbacea,
. patens and Z. caribaeum at concentrations between 0.78 and
00 g/ml (only 0.78, 12.5, 25.0, 50.0 and 200.0 g/ml are showed)
ith or without a metabolic system (S9 mixture) did not produce
rame-shift mutations in S. typhimurium His− strain TA98. The ace-
one extracts did not induce mutations by base-pair substitutions
n strain TA100 and did not produce mutations due to oxidative
amage in strain TA102 (Table 2).
iscussion
The anti-dermatophyte in vitro activities of several herbal
xtracts have been examined in previous reports (Machado et al.,
009; Ponnusamy et al., 2010; Sule et al., 2012). However, the
xtracts displayed much weaker activity than the commonly used
ynthetic anti-dermatophyte drugs, and only a small number of
hese extracts have been evaluated in experimental models, which
imits the use of these extracts as potential therapeutic agents
Evron et al., 1990; Mikaeili et al., 2012).
ig. 2. Experimental tinea pedis. The soles of animals treated for 7 days (day 21 post-infe
howed  severe carmine red erythema with 80–100% desquamation and severe crusting;
.5  mg/kg or Z. caribaeum 2.5 and 5 mg/kg, respectively, showed a small number of pink
reated  group showed no signs of toxicity. mice treated with 2.5 and 5 mg/kg of B. hartwegii or Z. caribaeum acetone extracts.
 daily for seven consecutive days. *p < 0.05 versus the non-treated group (One-way
In our experiments, we  found that B. hartwegii and H.  patens
extracts have the most optimal therapeutic potential because
these extracts exhibit comparable or even higher efﬁciencies
than the reference drugs against E. ﬂoccosum, M.  canis and
T. mentagrophytes.
Other plant extracts used in traditional medicine have shown
similar activities; for example, the hydroalcoholic extract of
Berberis aristata has activity against ten species of yeasts and
molds, including T. rubrum (MIC of 2.5 g/ml), Candida albicans
(MIC 1.25 g/ml), Cryptococcus albidus (MIC 1.25 g/ml), Blas-
toschizomyces capitatus (MIC 22 g/ml), Fusarium moniliforme (MIC
12 g/ml), and Fusarium semitectum (MIC 15 g/ml), and against
ﬁve species of Aspergillus with MIC  values between 0.3 and
10 g/ml (Sharma et al., 2008; Singh et al., 2007). The hydroalco-
holic extracts of species, such as Berberis asiatica, have reported
activity against C. albicans and Aspergillus ﬂavus (MIC = 1.25 and
0.62 g/ml, respectively); Berberis chitira against Aspergillus nidu-
lans, C. albidus and A. ﬂavus (MIC = 1.25 g/ml); and Berberis lycium
against Aspergillus terreus and Aspergillus spinulosus (MIC = 0.31 and
0.62 g/ml, respectively) (Singh et al., 2007).
ction). A, the uninfected, non-treated control; B, The infected, non-treated control
 C, D, F and G, The infected groups, treated with clotrimazole 1 mg/kg, B. hartwegii
 erythematous papules and less than 25% of desquamation at the site; and E, The
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Table  2
Mutagenicity of acetone extracts on S. typhimurium using the Ames test (plate incorporation assay), in presence or absence of metabolic activation.
Test substance Conc/ml Strains and metabolic system (S9)
TA98 TA100 TA102
−S9 +S9 −S9 +S9 −S9 +S9
B. hartwegii 12.5 g 23.9 ± 1.9 25.8 ± 1.3 167.6 ± 14.3 194.7 ± 9.3 313.0 ± 25.4 356.9 ± 39.4
25.0  g 25.4 ± 1.2 27.0 ± 1.6 204.1 ± 12.4 200.8 ± 9.3 322.6 ± 21.5 350.4 ± 23.5
50.0  g 22.0 ± 0.9 23.6 ± 1.8 175.6 ± 12.5 199.7 ± 8.2 271.9 ± 18.1 320.4 ± 28.1
D.  arboreus 12.5 g 30.8 ± 3.3 33.9 ± 4.5 184.6 ± 13.6 177.1 ± 13.0 366.9 ± 19.5 382.8 ± 72.5
25.0  g 30.1 ± 6.0 33.4 ± 3.7 199.9 ± 13.0 165.0 ± 10.2 384.2 ± 23.2 422.2 ± 67.5
50.0  g 35.3 ± 4.6 31.2 ± 4.2 183.1 ± 9.3 188.8 ± 13.5 398.1 ± 5.0 315.6 ± 62.5
E.  herbacea 12.5 g 26.3 ± 1.4 30.1 ± 1.9 199.3 ± 13.1 173.3 ± 9.5 312.3 ± 36.7 352.8 ± 17.4
25.0  g 26.4 ± 1.5 32.2 ± 1.8 214.2 ± 5.2 163.3 ± 9.5 394.6 ± 36.9 374.2 ± 22.9
50.0  g 31.6 ± 2.1 33.3 ± 1.8 199.7 ± 8.2 175.9 ± 3.8 283.7 ± 19.8 402.9 ± 26.4
H.  patens 12.5 g 25.9 ± 1.7 31.7 ± 2.5 186.0 ± 5.6 159.0 ± 4.2 334.2 ± 43.7 361.7 ± 37.0
25.0  g 26.4 ± 1.5 30.6 ± 1.7 183.4 ± 11.9 164.3 ± 6.8 294.9 ± 21.5 452.7 ± 47.5
50.0  g 24.6 ± 3.5 30.4 ± 2.2 189.7 ± 7.7 194.8 ± 11.4 285.8 ± 27.6 362.6 ± 35.9
Z.  caribaeum 12.5 g 23.9 ± 1.8 33.8 ± 2.1 213.4 ± 7.4 179.9 ± 6.9 333.2 ± 24.8 352.0 ± 25.8
25.0  g 22.7 ± 1.3 34.2 ± 1.0 197.3 ± 7.3 178.1 ± 12.1 357.8 ± 20.6 429.7 ± 22.3
50.0  g 24.3 ± 2.3 35.0 ± 2.2 200.3 ± 4.3 201.9 ± 12.6 352.4 ± 26.1 516.7 ± 16.7
PA  82.0 g 422.2 ± 30.9* 2055.1 ± 347.6*
2AA 10.0 g 4910.4 ± 187.8*
MNNG 10.0 g 13,248.3 ± 1036.6*
CP 500 g 558.8 ± 21.5*
Mit  C 2.0 ng 4386.9 ± 248.7*
DMSO 10.0. l 24.0 ± 2.1 33.7 ± 1.4 207.0 ± 5.6 195.2 ± 13.7 343.0 ± 33.7 417.3 ± 19.9
Data represent the mean ± SD of the number of histidine revertant colonies by plate in each treatment; three independent experimental series carried out in triplicate were
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terformed. Incubations were made in presence (+S9) and absence (−S9) of rat liver
-nitrosoguanidine; CP, cyclophosphamide; Mit  C, mitomycin C and DMSO, dimeth
* p < 0.05 (two-way ANOVA test and Bonferroni post hoc analysis).
This study is the ﬁrst report describing the in vitro antifun-
al activity of H. patens and is the ﬁrst to report this activity in
 species of the genus Hamelia. However, other biological activ-
ties have been previously reported, including the antibacterial
ctivity of the methanolic extract from the leaves of H. patens
gainst E. coli and Pseudomonas aeruginosa with MIC  = 2.5 mg/ml
Camporese et al., 2003). The cytotoxic activities of this specie
ave been reported against human epithelioid cervix carcinoma
ells (HeLa), CI50 = 13.3 g/ml; human prostate cancer cells (PC-3),
I50 = 41 g/ml; breast cancer human cells (MCF7 and MDA-MB-
31), CI50 = 63 and 45 g/ml; breast cancer mouse cells (4T-1),
I50 = 31 g/ml; colon carcinoma cells (HT-29), CI50 = 34 g/ml;
nd mouse leukemic monocyte macrophage cells (RAW-267),
I50 = 9 g/ml (Mena-Rejon et al., 2009; Taylor et al., 2013). H.
atens displayed anti-inﬂammatory activity against Croton oil-
nduced ear edema (Sosa et al., 2002) and increased the breaking
trength in a double incision wound healing bioassay model
Gomez-Beloz et al., 2003). A variety of alkaloids that are poten-
ially responsible for these biological activities have been described,
nd the most abundant alkaloids are isopteropodine, rumberine,
almirine, maroquine, (−)-hameline, aricine, pteropodine, uncar-
ne F and speciophylline (Paniagua-Vega et al., 2012; Reyes-Chilpa
t al., 2004). Many alkaloids have antifungal properties (Cimanga
t al., 1998; Hu et al., 2014; Zhou et al., 2003), and alkaloids can
onstitute up to 90% of the metabolites in H. patens extracts; thus,
e propose that this type of compound is also responsible for the
bserved antifungal activity.
To determine the activity against T. rubrum in the experimen-
al model, we chose to study the species B. hartwegii because this
lant showed good activity against the ﬁve dermatophytes evalu-
ted, and we examined Z. caribaeum due to the wide use of this
lant in traditional medicine for the treatment of skin diseases.
oreover, both species were selected due to the high availability
f these plants.
B. hartwegii and Z. caribaeum acetone extracts administered at
ifferent concentrations improved the skin lesions of experimen-
al tinea pedis. Doses of 2.5 mg/kg of Z. caribaeum and B. hartwegiisomal mix. PA, picrolonic acid; 2AA, 2-amino-anthracene; MNNG, methyl-N-nitro-
foxide.
extracts had comparable efﬁcacy to 1 mg  of clotrimazole. Further-
more, treatment with B. hartwegii (5 mg/kg) extract completely
healed the mycological infection after 7 days of treatment; thus,
this natural extract exhibited better activity than the reference
drug.
Currently, there have been no reports of any study on the species
B. hartwegii; however, other species of the same genus, such as B.
aristata, B. asiatica, Berberis criteria, B. lycium,  Berberis thunbergii,
Berberis heterophylla and Berberis aetnensis, have demonstrated
activity against a large number of pathogenic strains of the gen-
era Aspergillus and Candida (Freile et al., 2003; Iauk et al., 2007;
Li et al., 2007; Sharma et al., 2008; Singh et al., 2007). Berber-
ine, the compound responsible for this antifungal activity (Freile
et al., 2003; Soffar et al., 2001; Zhang et al., 2013a), has a
synergistic effect with ketokonazole (Zhou et al., 2012), micona-
zole (Wei  et al., 2011), ﬂuconazole (Iwazaki et al., 2010; Quan
et al., 2006) and amphotericin B (Han and Lee, 2005). This syn-
ergistic activity is due to the up-regulation of CDR1 mRNA and
the transport function of Cdr1p induced by ﬂuphenazine (Zhu
et al., 2014). Recent studies have found that berberine azoles
exhibited good antimicrobial activity against Candida mycoderma
(Zhang et al., 2013c), andberberine triazoles has good activity
against C. mycoderma and C. albicans. This activity was compa-
rable or better than the reference drugs berberine, norﬂoxacin
and ﬂuconazole (Zhang et al., 2013b). Thus, the antifungal activ-
ity observed in B. hartwegii could be due to the presence of
berberine.
There have been no reports on the antifungal activity of
Z. caribaeum,  but there have been reports on the activity of
the genus Zanthoxylum. The methanolic extract of Zanthoxylum
alatum exhibited potent antifungal activity against Alternaria alter-
nata, Alternaria brassicae, and Curvularia lunata (Guleria et al.,
2013), and Zanthoxylum capense exhibited antifungal activity
against Aspergillus fumigatus (Adamu et al., 2012). Extracts from
the leaf, fruit, stem, bark and root of Zanthoxylum americanum
demonstrated antifungal activity against C. albicans, Cryptococcus
neoformans and A. fumigatus in a disk diffusion assay (600 g/disk)
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Baﬁ-Yeboa et al., 2005). In other cases, alkaloids have been demon-
trated to be responsible for the antifungal activity of Zanthoxylum
lants; for example, three alkaloids with antifungal activity have
een isolated from Zanthoxylum nitidum (dictamnine, gamma-
agarine, and 5-methoxydictamnine) (Yang and Chen, 2008), and
ight active alkaloids have been isolated from Zanthoxylum rhetsa
nd Zanthoxylum chiloperone (Krohn et al., 2011; Soriano-Agaton
t al., 2005). Alkaloidal extract of Z. chiloperone var. angustifolium
as activity against C. albicans, A. fumigatus and T. mentagrophytes,
eing responsible for the biological activity two alkaloids (canthin-
-one and 5-methoxycanthin-6-one). The canthin-6-one has a
road antifungal spectrum against twelve species (MICs between
2.8 and 56.1 M/l) (Thouvenel et al., 2003). Thus, alkaloids must
e responsible for the biological activity observed in Z. caribaeum.
Medicinal plants and their derivatives have been used as
lternatives in allopathic medicine in many countries. Despite
he widespread use of medicinal plants, few scientiﬁc studies
ave been performed to examine the safety and efﬁcacy of tra-
itional remedies or pure compounds (Silva et al., 2011). Several
rugs for dermatophytosis, such as ketokonazole, itraconazole and
erbinaﬁne treatment, can cause hepatotoxicity (Andriole, 1999;
omchit et al., 2004; Zapata-Garrido et al., 2003); thus, it is impor-
ant to evaluate the potential toxic effects of extracts and natural
ompounds.
The results of the liver proﬁle test did not demonstrate any sig-
iﬁcant differences between the groups treated with B. hartwegii or
. caribaeum and the control group, indicating an absence of liver
amage caused by treatment. Liver histological sections showed
ormal hepatic architecture, normal hepatocytes, normal portal
riad and normal central vein. These observations, as well as
he serum levels of bilirubin and transaminases, established the
bsence of hepatocellular damage induced by the extracts. His-
ological analysis and biochemical parameters are essential for
valuating the toxicological risk of substances with biological activ-
ty because any changes in one of these parameters in animal
tudies can provide a high predictive value of potential damage in
umans (Carvalho et al., 2011; Olson et al., 2000; Silva et al., 2011).
Mutagenic compounds are potentially hazardous to humans.
ubstances that are mutagenic for bacteria are likely to be carcino-
enic in animals. Thus, all substances must be analyzed to establish
he risk-beneﬁt ratio. A useful procedure to detect mutagenic sub-
tances is the standard plate incorporation test (Ames et al., 1973).
ertain substances are not mutagenic by themselves; thus, the
mes test includes a metabolic system (mixture of liver enzymes
9).
None of the tested strains (TA98, TA100 and TA102) revealed
utagenic potential. All of the results were signiﬁcantly lower than
hose of the corresponding positive control (Two-way ANOVA test
nd Bonferroni post hoc analysis). Moreover, the number of rever-
ant colonies per plate containing the tested substance must be
t least more than twice the number of spontaneous revertants
Maron and Ames, 1983) for a substance to be considered muta-
enic, which was never observed in the tests with the acetone
xtracts of B. hartwegii, D. arboreus, E. herbacea, H. patens and Z.
aribaeum.  In addition, no dose-dependent effects were demon-
trated.
In summary, B. hartwegii and Z. caribaeum might be useful agents
gainst Trichophyton infections because these extracts exhibited
ood activity in in vitro and in vivo evaluations with no signs of
enotoxicity or hepatotoxicity.
Our ﬁndings justify the use of B. hartwegii and Z. caribaeum in
exican traditional medicine for the treatment of fungal skin infec-ions. These results in combination with the absence of hepatotoxic
r mutagenic effects indicated that these two species have sig-
iﬁcant potential for the development of new anti-dermatophyte
rugs.de Farmacognosia 25 (2015) 22–28 27
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